Given that PAI-1 levels are consistently elevated in patients with the metabolic syndrome, our finding of a direct role for PAI-1 in the regulation of lipid metabolism provides further support to the central role of PAI-1 in the cardiovascular complications of the metabolic syndrome, and in the molecular pathogenesis of the metabolic syndrome itself. Here, SERPINE1 is linked to metabolic syndrome.